The clinical use of arginine aspartate in male infertility.
130 male subjects (61 with asthenospermia, 69 with oligoasthenospermia) classified according to spermiologic patterns have been treated with different therapeutic outlines (gonadotrophins, antibiotica, arginine aspartate high levels, their associations); 89 subjects have been undergone with arginine aspartate, 41 without arginine aspartate. The results have been critically examined in order to different therapeutic outlines, to spermiogram, to diagnosis, to use of arginine aspartate in different spermiologic alterations, to use of arginine aspartate with respect to control groups, to arginine aspartate levels.
D000328:Adult; D001120:Arginine / Q000627:therapeutic use*; D001224:Aspartic Acid / Q000627:therapeutic use*; D005640:Follicle Stimulating Hormone / Q000097:blood; D005837:Genitalia, Male / Q000473:pathology; D012739:Gonadal Steroid Hormones / Q000097:blood; D006801:Humans; D007248:Infertility, Male / Q000188:drug therapy* / Q000473:pathology; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D012661:Semen / Q000032:analysis; D013076:Sperm Count; D013081:Sperm Motility
D012739:Gonadal Steroid Hormones; D001224:Aspartic Acid; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D001120:Arginine; C024891:arginine aspartate